Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
Xue H, Yu Z, Liu Y, et al. Int J Nanomedicine.2017;12:5271–5287. The authors of this paper have advised that Figure 8E is incorrect. Because of the similar label of groups LHD/miR-375 and LH/miR-375, the authors uploaded the wrong figure by mistake. The authors have confi...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/af63fabb28d740568236a29627b844f1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Xue H, Yu Z, Liu Y, et al. Int J Nanomedicine.2017;12:5271–5287.
The authors of this paper have advised that Figure 8E is incorrect. Because of the similar label of groups LHD/miR-375 and LH/miR-375, the authors uploaded the wrong figure by mistake. The authors have confirmed this correction will not make any change to the conclusion of their original research.
Read the original article |
|---|